French drug company Sanofi recalled Zantac after the United States Food and Drug Administration (FDA) found levels of N-nitrosodimethylamine (NDMA) that exceed the daily maximum allowed by the agency within the drug. NDMA is a probable human carcinogen. Similar levels of NDMA were found in some generic formulations of the drug, also known generically as ranitidine, as well.
Once this was discovered, Zantac was taken off the market. This is why you know longer see Zantac in drugstores. Other ranitidine products were pulled from the market because of the possibility of NDMA contamination.
In addition, some drugstores, supermarkets, and big-box stores pulled all ranitidine products from their shelves out of an overabundance of caution. The drug Axid and its generic, nizatidine, were also included in these recalls.
The FDA recommended that people taking prescription doses of ranitidine discuss their risks with their doctor whether they want to stop taking this medication or believe that they suffer adverse effects as a result of the it. There are numerous other medications on the market to reduce acid production or otherwise help with heartburn and reflux that you can replace Zantac with.
Understanding FDA Limits For NDMA
Zantac was taken off the market because it, along with other drugs that listed it as an ingredient, contained higher than allowed levels of an impurity known as NDMA. It is important to note that these levels were still very low. However, NDMA is known to cause cancer, liver failure, and other serious health conditions in animals, according to the FDA. It is also a probable human carcinogen.
This instance is not the first time the FDA has discovered medications exceeding the acceptable limits of NDMA and recommended that they be pulled from the market. According to the agency:
The allowable limit for ranitidine medications is 96 nanograms per day. FDA discovered levels higher than this occurred in laboratory testing and, as a result, advised the affected drug companies to recall their ranitidine products. They also asked companies whose products were not tested to conduct independent testing to ensure their products are safe.
NDMA is a “Probable Carcinogen” According to The FDA
NDMA is primarily used in scientific settings to induce tumor growth in laboratory animals. It is a fairly common environmental contaminant, as well. Many people likely consume low levels daily in water, meats, dairy products, and vegetables. It is generally not thought to cause any harm at very low levels, such as those allowable by the FDA.
However, in larger doses or when taken in moderate doses regularly over a long period of time, it may be harmful. According to the Centers for Disease Control and Prevention, NDMA can cause lung and liver cancer in mice, rats, hamsters, and other animals when administered in relatively low doses over several weeks or months. In higher doses, it may cause internal bleeding, liver failure, and death.
While there are no scientifically documented cases that can prove NDMA caused cancer in a person as of March 2020, the FDA still considers the contaminant a “probable carcinogen” in humans. The claimants in Zantac cancer lawsuits hope to prove NDMA causes cancer and recover compensation for their related damages.
Pursuing Compensation After Zantac Was Taken Off The Market
If you took Zantac or another ranitidine product and were later diagnosed with cancer, you may be eligible to join dozens of others in filing a case against the drug manufacturer. Your cancer may have been preventable, and you may be able to hold the drug company that caused it accountable.
There is a multidistrict litigation (MDL 2924) currently underway in regard to Zantac and ranitidine cancer cases as of March 2020 according to United States Courts. You may be able to join this group of claimants and pursue compensation based on the facts of your case.
Talk to a Zantac Cancer Lawyer About Your Case
If you believe that you may be eligible to take legal action based on your cancer diagnosis after Zantac was taken off the market, Zanes Law can help. We are accepting ranitidine cases from all states at this time. There may be time limits on how long you have to take legal action, so reach out to us today for a free case review. Your review and sign-up can all be done in one phone call.
You can reach a Zantac cancer attorney about your case today by calling Zanes Law at (866) 499-8989. Your initial case review and consultation with our team is always free, and we handle these cases on a contingency fee basis. You do not owe us any attorney’s fees until we reach a settlement in your case.